22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
  • News

  • Press Releases
Jan 24, 2023 9:20am EST

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position

Jan 23, 2023 9:20am EST

22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs

Jan 18, 2023 9:25am EST

22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown

Jan 17, 2023 9:00am EST

FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers

Dec 13, 2022 9:25am EST

22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law

Dec 08, 2022 1:00pm EST

22nd Century Group Provides Update on Grass Valley Facility

Nov 21, 2022 4:10pm EST

22nd Century Group Provides Update on Incident at Grass Valley Facility

Nov 16, 2022 9:25am EST

22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands

Nov 15, 2022 9:25am EST

22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas

Nov 14, 2022 8:19am EST

22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...38
Next
  • Email Alerts
  • Contact
  • RSS News Feed
© 2023 22nd Century Group, Inc. All Rights Reserved.
Privacy Policy / CCPA Disclaimer Sitemap